Lion Point Capital »

Amylyx Pharmaceuticals shares owned by Lion Point Capital

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 14k 14.72

More positions owned by Lion Point Capital

Semtech Corporation (SMTC)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Marinus Pharmaceuticals Com New (MRNS)
Ardelyx (ARDX)
Milestone Pharmaceuticals (MIST)
Harpoon Therapeutics Com New
Burgerfi International (BFI)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Battalion Oil Corp (BATL)
Cymabay Therapeutics
Fennec Pharmaceuticals (FENC)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Syndax Pharmaceuticals (SNDX)

View all positions for Lion Point Capital

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals